Multidisciplinary evaluation at baseline and during treatment improves the rate of compliance and efficacy of deferasirox in elderly myelodysplastic patients-Reference-Cited by-同舟云学术

Multidisciplinary evaluation at baseline and during treatment improves the rate of compliance and efficacy of deferasirox in elderly myelodysplastic patients

Published:2016-10-22 Issue:2 Volume:22 Page:380-386
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Del Corso Lisette,Biale Lucia,Parodi Emanuele Luigi,Russo Rodolfo,Filiberti Rosa,Arboscello Eleonora

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-016-1042-5.pdf

Reference38 articles.

1. Tefferi A, Vardiman JW (2009) Myelodysplastic syndromes. N Engl J Med 361(19):1872–1885. doi: 10.1056/NEJMra0902908

2. Aul C, Giagounidis A, Germing U (2001) Epidemiological features of myelodysplastic syndromes: results from regional cancer surveys and hospital-based statistics. Int J Hematol 73(4):405–410

3. Cogle CR (2015) Incidence and Burden of the Myelodysplastic Syndromes. Current hematologic malignancy reports 10(3):272–281. doi: 10.1007/s11899-015-0269-y

4. Ma X, Does M, Raza A et al (2007) Myelodysplastic syndromes: incidence and survival in the United States. Cancer 109(8):1536–1542. doi: 10.1002/cncr.22570

5. Greenberg P, Cox C, LeBeau MM et al (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079–2088

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metals and Metal Antagonists;Side Effects of Drugs Annual;2017